ENVERIC BIOSCIENCES, INC. Business Combination, Contingent Consideration, Liability
ENVERIC BIOSCIENCES, INC. (ENVB) had Business Combination, Contingent Consideration, Liability of $1.00 million as of 2019-12-31, per its 10-K filed 2020-03-25.
Discontinued › Balance Sheet › Liabilities
us-gaap:BusinessCombinationContingentConsiderationLiability · last filed 2020-03-25
- 2019-12-31: Business Combination, Contingent Consideration, Liability $1.00M.
- 2019-09-30: Business Combination, Contingent Consideration, Liability $2.50M.
- 2019-06-30: Business Combination, Contingent Consideration, Liability $2.50M.
- 2019-03-31: Business Combination, Contingent Consideration, Liability $2.60M.
| Period end | Business Combination, Contingent Consideration, Liability |
|---|---|
| 2019-12-31 | $1.00M 10-K · filed 2020-03-25 |
| 2019-09-30 | $2.50M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $2.50M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $2.60M 10-Q · filed 2019-05-14 |
| 2018-12-31 | $3.30M 10-K · filed 2019-03-26 |
| 2018-09-30 | $3.10M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $14.60M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $14.70M 10-Q · filed 2018-05-15 |
| 2017-09-30 | $19.32M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $19.32M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $20.16M 10-Q/A · filed 2017-05-15 |
| 2015-09-30 | $400.00K 10-Q · filed 2015-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |